GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Shiller PE Ratio

AstraZeneca (AstraZeneca) Shiller PE Ratio

: 61.21 (As of Today)
View and export this data going back to 1993. Start your Free Trial

As of today (2024-04-20), AstraZeneca's current share price is $68.56. AstraZeneca's E10 for the quarter that ended in Dec. 2023 was $1.12. AstraZeneca's Shiller PE Ratio for today is 61.21.

The historical rank and industry rank for AstraZeneca's Shiller PE Ratio or its related term are showing as below:

AZN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 4.62   Med: 23.51   Max: 75.22
Current: 61.88

During the past years, AstraZeneca's highest Shiller PE Ratio was 75.22. The lowest was 4.62. And the median was 23.51.

AZN's Shiller PE Ratio is ranked worse than
85.8% of 514 companies
in the Drug Manufacturers industry
Industry Median: 24.545 vs AZN: 61.88

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AstraZeneca's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.310. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $1.12 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


AstraZeneca Shiller PE Ratio Historical Data

The historical data trend for AstraZeneca's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.82 35.15 52.72 71.22 59.93

AstraZeneca Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.22 69.34 66.74 65.79 59.93

Competitive Comparison

For the Drug Manufacturers - General subindustry, AstraZeneca's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca Shiller PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Shiller PE Ratio falls into.



AstraZeneca Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AstraZeneca's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=68.56/1.12
=61.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, AstraZeneca's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.31/130.0000*130.0000
=0.310

Current CPI (Dec. 2023) = 130.0000.

AstraZeneca Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.200 99.300 0.262
201406 0.315 99.800 0.410
201409 0.100 100.000 0.130
201412 -0.125 99.900 -0.163
201503 0.220 99.600 0.287
201506 0.275 100.100 0.357
201509 0.300 100.200 0.389
201512 0.315 100.400 0.408
201603 0.255 100.400 0.330
201606 -0.001 101.000 -0.001
201609 0.400 101.500 0.512
201612 0.725 102.200 0.922
201703 0.210 102.700 0.266
201706 0.190 103.500 0.239
201709 0.270 104.300 0.337
201712 0.515 105.000 0.638
201803 0.135 105.100 0.167
201806 0.135 105.900 0.166
201809 0.170 106.600 0.207
201812 0.410 107.100 0.498
201903 0.235 107.000 0.286
201906 0.045 107.900 0.054
201909 0.115 108.400 0.138
201912 0.120 108.500 0.144
202003 0.295 108.600 0.353
202006 0.290 108.800 0.347
202009 0.245 109.200 0.292
202012 0.390 109.400 0.463
202103 0.590 109.700 0.699
202106 0.210 111.400 0.245
202109 -0.550 112.400 -0.636
202112 -0.110 114.700 -0.125
202203 0.125 116.500 0.139
202206 0.115 120.500 0.124
202209 0.525 122.300 0.558
202212 0.290 125.300 0.301
202303 0.580 126.800 0.595
202306 0.585 129.400 0.588
202309 0.440 130.100 0.440
202312 0.310 130.000 0.310

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AstraZeneca  (NAS:AZN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AstraZeneca Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca (AstraZeneca) Business Description

Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.

AstraZeneca (AstraZeneca) Headlines

From GuruFocus